Cancer Vaccine Research Gets a Boost (HealthDay)
25th Nov 2005, 14:27 GMT
HealthDay - FRIDAY, Nov. 25 (HealthDay News) -- Moving closer to the elusive goal of a cancer vaccine, U.S. scientists say they've neutralized a class of immune cells that usually impair vaccine effectiveness.
Cancer Vaccine Research Gets a Boost (HealthDay) related news:
- Cancer Vaccine Research Gets a Boost (HealthDay) —
- Cancer Vaccine Research Gets a Boost — MedicineNet Cancer Specialty
- Injected Virus Kills Brain Cancer in Mice (HealthDay) — Yahoo! News: Health News
- Too Many Cancer Patients Continue to Smoke (HealthDay) — Yahoo! News: Health News
- Laser Surgery Effective for Liver Cancer, Research Shows (HealthDay) — Yahoo! News: Health News
- Genes May Predict Childhood Cancer Prognosis (HealthDay) — Yahoo! News: Health News
- Distance Can Decide Breast Cancer Care (HealthDay) — Yahoo! News: Health News
- Hunt for cancer vaccines continues despite failures — OrlandoSentinel.com -
- Hereditary breast cancer research funding 'inadequate' — KeralaNext: Health
- Killing regulatory T cells boosts effectiveness of cancer vaccine — EurekAlert! - Medicine and Health
Latest news from Yahoo! News: Health News:
- Health care costs could jump 10 percent (AP)
- Results mixed on Merck's new painkiller (AP)
- More South Africans get AIDS medicine (AP)
- Europe to draw up strategy against obesity (AFP)
- Clinical Trials Update: Nov. 13, 2006 (HealthDay)
- Pharmacy Program Helps Elderly Take Their Meds (HealthDay)
- Red meat may raise breast cancer risk (AP)
- Insurers' plan aims to cover uninsured (AP)
- FDA: Tamiflu patients need monitoring (AP)
- Flu Drug Tamiflu May Cause Odd Behavior in Children (HealthDay)